undefined
Skip to main content
Global Site|en

Add a bookmark to get started

Global Site
Africa
MoroccoEnglish
South AfricaEnglish
Asia Pacific
AustraliaEnglish
Hong Kong SAR ChinaEnglish简体中文
KoreaEnglish
New ZealandEnglish
SingaporeEnglish
ThailandEnglish
Europe
BelgiumEnglish
Czech RepublicEnglish
HungaryEnglish
IrelandEnglish
LuxembourgEnglish
NetherlandsEnglish
PolandEnglish
PortugalEnglish
RomaniaEnglish
Slovak RepublicEnglish
United KingdomEnglish
Middle East
BahrainEnglish
QatarEnglish
North America
Puerto RicoEnglish
United StatesEnglish
OtherForMigration
Website_Hero_Abstract_Architectural_Shapes_P_0031_Mono
7 November 20181 minute read

DLA Piper advises ResMed in agreement to acquire MatrixCare for US$750 million

DLA Piper represented ResMed (NYSE: RMD), a world-leading connected health company, in a definitive agreement to acquire privately held MatrixCare, a leader in US long-term post-acute care software, serving more than 15,000 providers across skilled nursing, life plan communities, senior living and private duty, for US$750 million.

The transaction is expected to close by the end of the second quarter of ResMed's fiscal year 2019. MatrixCare will continue to operate as a standalone business within ResMed's software-as-a-service (SaaS) portfolio, with targeted commercial, technical and operating links to ResMed and Brightree.

The DLA Piper team was led by partner Martin Nichols (San Diego) and included partners Neil Balmert, Mark Lehberg (both of San Diego), Nate McKitterick, Cisco Palao-Ricketts (both of Silicon Valley), Anna Spencer (Atlanta) and Paolo Morante (New York); and associates Chris Stevenson (Seattle), Jennifer Cumming (San Diego) and Milton Gregory (Atlanta).